Lekhram Changoer
Direttore Tecnico/Scientifico/R&S presso CANAFARMA HEMP PRODUCTS CORP.
Patrimonio netto: 2 M $ in data 30/06/2024
Profilo
Lekhram Changoer is the founder of CanChew Biotechnologies LLC, which was founded in 2012.
He held the title of Director from 2012 to 2013.
Mr. Changoer is also the founder of APIRX Pharmaceuticals USA LLC.
Mr. Changoer's current jobs include being a Director & Partner at Stichting Sanammad since 2009, a Director & Partner at Sanammad Pharmaceuticals BV since 2014, and the Chief Chemist & Technologist at Canafarma Hemp Products Corp.
Additionally, he is the Chief Technology Officer at Incannex Healthcare, Inc. starting in 2023.
Mr. Changoer's former job was as the Director & Chief Technology Officer at AXIM Biotechnologies, Inc. from 2014 to 2020.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
4.03% | 28/11/2023 | 639 549 ( 4.03% ) | 2 M $ | 30/06/2024 |
Posizioni attive di Lekhram Changoer
| Società | Posizione | Inizio |
|---|---|---|
| CANAFARMA HEMP PRODUCTS CORP. | Direttore Tecnico/Scientifico/R&S | - |
| INCANNEX HEALTHCARE INC. | Direttore Tecnico/Scientifico/R&S | 05/07/2023 |
| Stichting Sanammad | Direttore/Membro del Consiglio | 01/01/2009 |
| Sanammad Pharmaceuticals BV | Direttore/Membro del Consiglio | 01/01/2014 |
Precedenti posizioni note di Lekhram Changoer
| Società | Posizione | Fine |
|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 06/05/2020 |
APIRX Pharmaceuticals USA LLC
 APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Fondatore | - |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| INCANNEX HEALTHCARE INC. | Health Technology |
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| CANAFARMA HEMP PRODUCTS CORP. | Process Industries |
| Aziende private | 4 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV | |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
- Borsa valori
- Insiders
- Lekhram Changoer
